Clinical trials
Recruiting Phase 2 trials in Greece
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
70 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 7 |
| 2025 | 25 |
| 2026 | 25 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 70 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 9 |
| AstraZeneca | 6 |
| Sanofi | 4 |
| Philogen S.p.A. | 3 |
| AbbVie | 2 |
| GlaxoSmithKline | 2 |
| Immunovant Sciences GmbH | 2 |
| Janssen Research & Development, LLC | 2 |
| Karyopharm Therapeutics Inc | 2 |
| Pfizer | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 4 |
| Neoplasms | 4 |
| Colitis, Ulcerative | 3 |
| Idiopathic Pulmonary Fibrosis | 3 |
| Multiple Myeloma | 3 |
| Basal Cell Carcinoma | 2 |
| Gram-Negative Bacterial Infections | 2 |
| Graves Disease | 2 |
| Lung Neoplasms | 2 |
| Myasthenia Gravis | 2 |
Trials
Showing 1 to 25 of 70. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.